Saiama N Waqar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Idiopathic Pulmonary Fibrosis

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of thoracic disease

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Saiama N Waqar, Ramaswamy Govindan
Novel Therapies in Cancer: Trials and Tribulations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Saiama N Waqar, Ramaswamy Govindan
Novel Therapies in Cancer: Trials and Tribulations. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waqar
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 16 (6) (2024)
Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waqar
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 16 (6) (2024)
Saiama N Waqar, Clifford G Robinson, Anthony J Olszanski, Alexander I Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Marianna Grinberg, Annick Seithel-Keuth, Ivan Diaz-Padilla, Jordan D Berlin
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors. Investigational new drugs 40 (3) (2022)